Data / Drug companies / Neomycin sulfate
Neomycin sulfate: 12 companies and 12 products in the FDA NDC directory
Neomycin sulfate is listed in the FDA National Drug Code Directory by 12 companies, with 12 products in commercial distribution. 4 of the products (33.3%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are ointment; tablet; granule, and the newest product started marketing on July 22, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 12
- Products
- 12
- Generic (ANDA) products
- 4 (33.3%)
- Application numbers
- 5
- Routes
- Topical, Oral
- Brand names
- Antibiotic, First Aid Only Neomycin Antibiotic, Single Antibiotic With Neomycin, Pomada de Sulfa, Pomada Sulfa First Aid Antibiotic
- openFDA record search
- api.fda.gov
Companies that list neomycin sulfate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Acme United Corporation | 1 | ointment | Over the counter monograph drugs | July 16, 2021 |
| Aldermed Inc. | 1 | ointment | Over the counter monograph drugs | January 1, 2026 |
| Chartwell RX, LLC | 1 | tablet | Generic drugs (ANDA) | June 10, 2016 |
| Compania Internacional de Comercio, S.a.p.i de C.V. | 1 | ointment | Over the counter monograph drugs | July 30, 2016 |
| Grandall Distributing, LLC | 1 | ointment | Over the counter monograph drugs | July 18, 2024 |
| Menper Distributors, Inc. | 1 | ointment | Over the counter monograph drugs | February 21, 2012 |
| Remedyrepack Inc. | 1 | tablet | Generic drugs (ANDA) | April 24, 2026 |
| Safetec of America, Inc. | 1 | ointment | Over the counter monograph drugs | November 13, 2008 |
| Shaanxi Shuvita Biotech Co., Ltd | 1 | granule | Over the counter monograph drugs | July 22, 2026 |
| Solaris Pharma Corporation | 1 | tablet | Generic drugs (ANDA) | June 1, 2023 |
| Teva Pharmaceuticals USA, Inc. | 1 | tablet | Generic drugs (ANDA) | September 30, 1990 |
| Total Resources International, Inc | 1 | ointment | Over the counter monograph drugs | October 7, 2019 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Ointment | 7 | 58.3% |
| Tablet | 4 | 33.3% |
| Granule | 1 | 8.3% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 8 | 66.7% |
| Generic drugs (ANDA) | 4 | 33.3% |
Pharmacologic classes
| Class | Products |
|---|---|
| Aminoglycoside Antibacterial | 12 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.